ReviewAntioxidants & redox signaling2015
NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress.
Becky A Diebold et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
this paperpooled itcites it